1. |
Is it interpatient or intrapatient variability in response? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
2. |
Olanzapine confers rapid QOL benefits in bipolar disorder |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
3. |
Naproxen, celecoxib reasonably cost effective for knee OA in Taiwan |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
4. |
All ages can breathe easier with ciclesonide |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 5-6
S Sullivan,
Preview
|
|
摘要:
Ciclesonide [Alvesco] is as effective as fluticasone propionate in the treatment of asthma, according to studies presented at the 14th Annual Congress of the European Respiratory Society (ERS) [Glasgow, UK; September 2004]. Inhaled ciclesonide improved lung function, reduced the symptoms of asthma and reduced the need for rescue medication in children, adolescents and adults with asthma. Furthermore, ciclesonide can be administered once daily and appears to have minimal effects on cortisol levels, suggesting that ciclesonide is an inhaled corticosteroid offering improved compliance and tolerability.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
5. |
Differential effects of PDE-5 inhibitors on pulmonary circulation |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
6. |
VX 702 may reduce CRP levels in patients with ACS |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
7. |
Capecitabine/mitomycin effective in gastrointestinal cancers |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
8. |
Sirolimus-eluting stent superior in diabetes |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 9-10
S Sullivan,
Preview
|
|
摘要:
A sirolimus-eluting stent [Cypher] reduces the incidence of restenosis in patients with diabetes mellitus, according to a study presented at the 16th Annual Scientific Symposium of Transcatheter Cardiovascular Therapeutics (TCT) [Washington, DC, US; September-October 2004]. Patients receiving a sirolimus-eluting stent experienced a significant reduction in the restenosis rate and in-segment late lumen loss, compared with bare metal stent recipients. Furthermore, the incidence of major adverse cardiac events was significantly lower among sirolimus-eluting stent, compared with bare metal stent, recipients.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
9. |
Cefdinir: advantages in paediatric otitis media |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
10. |
SLI 381 effective in adolescents with ADHD |
|
Inpharma Weekly,
Volume &NA;,
Issue 1461,
2004,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|